MAVI ADVANCES VASCULAR CARE THROUGH LEADING-EDGE CLINICAL RESEARCH
Our clinical research division’s mission is to foster advances in vascular disease, therapies and technologies. Our patients have access to an array of clinical trials as a way to play a more active role in their own health care, gain access to new research treatments before they are widely available and help others by contributing to medical research.
The surgeons at MAVI participate in more research studies than any other practice in the region. Participation is voluntary for eligible patients, and supported by a trial coordinator and a dedicated team of investigators. The trials offered through MAVI involve retrospective, device, interventional and biologic research.
For specific information about all of the studies we’re currently offering, or to find out whether you’re eligible for participation, call 816-842-5555 and ask for the clinical research division or email email@example.com.
Following are just several of the clinical studies in progress at MAVI. All clinical trials can be found on clinicaltrials.gov.
Endologix EVASII - Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair using the Nellix® System. The objective is to study the safety and effectiveness of the Nellix System for Endovascular Abdominal Aortic Aneurysm (AAA) repair. Patients diagnosed with an abdominal aortic or aortoiliac aneurysm who are considered candidates for endovascular repair and who meet the study eligibility criteria may be screened for enrollment in the study. OPEN FOR ENROLLMENT
Endologix Leopard Study
A multicenter, prospective, randomized, post-market, real-world study to assess outcomes of patients treated with the AFX® System compared to other EVAR devices for endovascular aortic aneurysm repair. CLOSED TO ENROLLMENT
A prospective, multicenter, single-arm study to evaluate post-market safety and effectiveness of GORE VIABAHN Endoprosthesis for treatment of In-Stent Restenosis of the SFA. ENROLLMENT CLOSED